---
title: "ENTERPRISE THERAPEUTICS LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4072bc90-158d-54d0-93b7-b7b54b04cd12
json: https://whiteintel.dev/api/public/dossier/4072bc90-158d-54d0-93b7-b7b54b04cd12
identifier: oo:GB-COH-09022750
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ENTERPRISE THERAPEUTICS LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-09022750`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/4072bc90-158d-54d0-93b7-b7b54b04cd12  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4072bc90-158d-54d0-93b7-b7b54b04cd12  

## Ownership & control

### Owners / controllers

- **ENTERPRISE THERAPEUTICS HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/f1797241-5584-5a62-8f40-092c36a2248e
- **TOUCHSTONE INNOVATIONS BUSINESSES LLP** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/5c736245-7eba-5c88-b9ad-0f7141e28d99
- **EPIDAREX CAPITAL PARTNERS LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a
- **ENTERPRISE THERAPEUTICS HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f1797241-5584-5a62-8f40-092c36a2248e
- **IP2IPO PORTFOLIO (GP) LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/d551daa7-4246-5c31-916b-1a98a6082f52

### UBO chain (walk to the ultimate owner)

A **69-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `09022750`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2014-05-02
- **Registered office:** Sussex Innovation Centre Science Park Square, Falmer, Brighton, BN1 9SB, England
- **SIC:** 72110

### Officers

- BOYD, Philip James, Dr — secretary · appointed 2016-12-15
- FORD, John William, Dr — director · British · appointed 2016-11-03
- DANAHAY, Henry, Dr — director · British · appointed 2014-05-02 · resigned 2014-12-08
- DZIKOWSKI, Bart — director · Canadian · appointed 2020-01-01 · resigned 2021-05-20
- FINAN, Peter Michael, Dr — director · British · appointed 2014-12-08 · resigned 2021-05-20
- GOSLING, Martin, Dr — director · British · appointed 2014-05-02 · resigned 2018-04-06
- MAYWEG, Alexander Volker, Dr — director · German · appointed 2018-04-06 · resigned 2021-05-20
- MCCARTHY, Clive, Dr — director · British · appointed 2014-05-02 · resigned 2014-12-08
- MORRIS, David — director · American · appointed 2018-04-06 · resigned 2020-01-01
- MULDER, Geert-Jan — director · Dutch · appointed 2018-04-06 · resigned 2021-05-20
- MUNSHI, Amit — director · American,Swiss · appointed 2019-04-02 · resigned 2021-05-20
- RICHARDSON, Johnathan Craig, Dr — director · British · appointed 2019-09-10 · resigned 2021-05-20
- ROPER, Elizabeth — director · Irish · appointed 2014-12-08 · resigned 2019-04-02
- SONI, Bobby G., Dr — director · American · appointed 2018-04-06 · resigned 2019-09-10
- STOREY, John Mervyn David, Professor — director · British · appointed 2014-05-02 · resigned 2014-12-08
- WOODMAN, Robbie, Dr — director · British · appointed 2015-05-05 · resigned 2018-02-15
- [IP2IPO SERVICES LIMITED](https://whiteintel.dev/entity/b21b9a75-76e8-5cdc-9da2-2bf770496dd4) — corporate director · appointed 2018-02-15 · resigned 2018-04-06

### Beneficial owners (Persons with Significant Control)

- [Enterprise Therapeutics Holdings Limited](https://whiteintel.dev/entity/f1797241-5584-5a62-8f40-092c36a2248e) — 75–100% shares · corporate PSC · United Kingdom — since 2020-10-05
- [Ip2ipo Portfolio (Gp) Limited](https://whiteintel.dev/entity/d551daa7-4246-5c31-916b-1a98a6082f52) — 25–50% shares · corporate PSC · United Kingdom — ceased 2020-10-05
- [Touchstone Innovations Businesses Llp](https://whiteintel.dev/entity/5c736245-7eba-5c88-b9ad-0f7141e28d99) — 25–50% shares · corporate PSC · United Kingdom — ceased 2020-10-05
- [Epidarex Capital Partners Limited](https://whiteintel.dev/entity/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a) — 25–50% shares · corporate PSC · Scotland — ceased 2018-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09022750
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/09022750

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **ENTERPRISE THERAPEUTICS LTD** — https://whiteintel.dev/entity/4072bc90-158d-54d0-93b7-b7b54b04cd12 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ENTERPRISE THERAPEUTICS LTD**. Human view: https://whiteintel.dev/entity/4072bc90-158d-54d0-93b7-b7b54b04cd12 · Structured JSON: https://whiteintel.dev/api/public/dossier/4072bc90-158d-54d0-93b7-b7b54b04cd12._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._